Researchers question relationship between R&D costs and drug prices; Alexa uses WebMD to answer health questions; lawmakers push GAO to investigate orphan drugs
Why Any Merger is the Last Resort of Lousy Marketers
Really? Is this the new healthcare math — the fewer the insurance companies, the greater the competition and the lower the premiums?
Infographic: Type 2 diabetes, a country-by-country snapshot
July 28, 2016
12:45 pm
Type 2 diabetes is on the rise, around the world. The IMS Institute for Healthcare Informatics breaks down diabetes prevalence in Brazil, Mexico, Saudi Arabia, the U.K., and the U.S.
